Merck Serono and Pfizer are to work with the Broad Institute in Cambridge, Massachusetts to undertake genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) patients.

Merck Serono's Bavencio is the only checkpoint inhibitor to be approved for first-line maintenance treatment of bladder cancer in Europe, but UK cost-effectiveness agency NICE says it is too ...

Dr Reddy's, Merck Serono in pact to develop biotech drugs Germany's Merck KGaA, have entered into a partnership to co-develop a portfolio of biosimilar compounds (biotechnology drugs) in the ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

The Accelerated Cure Project for Multiple Sclerosis launched a new website to better support caregivers of people with MS.

In Europe and Canada, where the drug is marketed by Geneva-based Merck Serono and Serono of Mississauga, Ontario, respectively, regulators have taken Raptiva off the market, stating that the ...